First-line endocrine therapy combined with CDK 4/6 inhibitor in disseminated carcinomatosis of bone marrow (DCBM) luminal breast cancer: a case report

First-line endocrine therapy combined with CDK 4/6 inhibitor in disseminated carcinomatosis of bone marrow (DCBM) luminal breast cancer: a case report

Abstract Background Metastatic breast cancer especially in disseminated carcinomatosis of bone marrow (DCBM) poses a life-threatening risk, often requiring systemic chemotherapy. This situation lacks a cure, emphasizing symptom relief and quality of life. The documented occurrence of DCBM is merely...

Full description

Bibliographic Details
Main Authors: Eko Adhi Pangarsa, Putri Dwi Astuti, Daniel Rizky, Kevin Tandarto, Budi Setiawan, Andreas Agung Winarno, Damai Santosa, Catharina Suharti
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Journal of Medical Case Reports
Subjects:
Breast cancer
CDK 4/6 inhibitor
Chemotherapy
Endocrine therapy
Visceral crisis
Online Access:https://doi.org/10.1186/s13256-024-04922-4

Internet

https://doi.org/10.1186/s13256-024-04922-4

Similar Items